Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NBTY on NYSE

This article was originally published in The Tan Sheet

Executive Summary

Bohemia, N.Y.-based firm to trade common stock shares on New York Stock Exchange, NBTY announces Sept. 2. The company will remain on Nasdaq through close of business Sept. 18, begin trading on NYSE Sept. 19 under symbol "NTY." NBTY's issue closed Tuesday at 27.04, up 2.2%. The stock is almost back to its 52-week high of 27.40 on Aug. 22...

You may also be interested in...



EU Pharma Strategy Offers Window For Regulatory Optimization

Attendees to Medicines for Europe’s Regulatory Affairs and Pharmacovigilance virtual conference heard that a window of opportunity to optimize the region’s regulatory landscape is now “wide open” with the advent of the new EU Pharmaceutical Strategy.

Pandemic Leaves Medtech With $500bn In M&A Firepower

EY’s M&A Firepower report predicts very active M&A activity for medtechs in 2021, driven by diagnostics and digital health, but with some headwinds remaining.

Execs On The Move, January 2021

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Topics

UsernamePublicRestriction

Register

OM013164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel